What is ARKG's market cap?

$1.93B, based on the Nov 12 close of $44.32.

Cboe BZX · ARKG

ARK Genomic Revolution ETF (ARKG)

$44.32−4.24%

Close Nov 12, 2026 · split-adjusted

Nov 12, 2026$44.32▲ 56.61% in range

Nov 12, 2025Low $24.82 · High $56.77Nov 12, 2026

What changed · written from our data

As of Nov 12, 2026

ARK Genomic Revolution ETF closed at $44.32 on Nov 12, down 4.24%, 21.9% below its 52-week closing high. Volume of 3.7M shares was 0.65× its 20-day average (below normal).

Split-adjusted performance: -8.2% over one month, +51.9% over six months, +53.8% over one year.

Short interest was 16.5M shares at the Oct 30 settlement, down 26.0% from the prior report (2.6 days to cover).

Market cap$1.93B43.5M shares

Revenue · quarter——

Diluted EPS——

P/E · TTM—

Net margin—

Dividend yieldNone$0.3824 last paid

52-week range24.82 – 56.77−21.9% from high

Volume3.7M0.65× 20-day avg

Volatility · 60d56.7%Annualised

Short % of float—2.6 days to cover

Net cash—

Next earnings—Not scheduled

Split-adjusted performance

1W −0.7%1M −8.2%3M +2.0%6M +51.9%YTD +53.0%1Y +53.8%3Y +69.7%5Y −43.6%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Short interest

Details →

Shares short16.5M−26.0% vs prior

Days to cover2.6Settled Oct 30

% of float—

Short vol. 10d52.0%of daily volume

News about ARK Genomic Revolution ETF

All news →

No recent articles focused on ARK Genomic Revolution ETF. 4 articles mention it in passing.

Quick answers

What is ARKG's market cap?: $1.93B, based on the Nov 12 close of $44.32.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology